Free Trial
NASDAQ:GNOM

Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News

$8.56 -0.17 (-1.95%)
Closing price 03:47 PM Eastern
Extended Trading
$8.56 0.00 (0.00%)
As of 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Key Stats

Today's Range
$8.51
$8.67
50-Day Range
$7.43
$8.74
52-Week Range
$6.80
$11.88
Volume
34,062 shs
Average Volume
61,959 shs
Market Capitalization
$45.28 million
Assets Under Management
$46.32 million
Dividend Yield
0.12%
Net Expense Ratio
0.50%
Aggregate Rating
Moderate Buy

ETF Overview

Global X Genomics & Biotechnology ETF Expenses

TypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.57%0.56%0.54%0.53%
Other Expenses0.00%0.58%0.56%0.52%0.56%
Total Expense0.50%0.74%0.76%0.74%0.73%
Fee Waiver0.00%-0.76%-0.66%-0.50%-0.63%
Net Expense0.50%0.60%0.63%0.63%0.60%
Receive GNOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

GNOM ETF News Headlines

10x Genomics Misses Revenue Forecast
​9 AI Stocks Set to Soar Amid U.S.-China Trade Tensions
The escalating U.S.-China trade tensions are reshaping the AI landscape. Companies like Nvidia are facing significant revenue hits with the U.S. imposing new export restrictions on advanced AI chips to China. This shift opens doors for U.S.-based AI companies poised to fill the gap.
Global X Genomics & Biotechnology UCITS ETF (GNOM.L)
GNOM Global X Genomics & Biotechnology ETF
See More Headlines

GNOM ETF - Frequently Asked Questions

Global X Genomics & Biotechnology ETF's stock was trading at $9.71 at the beginning of 2025. Since then, GNOM shares have decreased by 11.8% and is now trading at $8.56.

Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Global X Genomics & Biotechnology ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Teladoc Health (TDOC), Intel (INTC), Alibaba Group (BABA) and PayPal (PYPL).

Fund Details

Issuer
Global X
Fund Name
Global X Genomics & Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:GNOM
Inception Date
4/5/2019
Fund Manager
Chang Kim, James Ong, Nam To, Wayne Xie

Fund Focus

Asset Class
Equity
Benchmark
Solactive Genomics Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
51

Fund Statistics

Assets Under Management
$46.32 million
Average Daily Volume
$0.00
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
Global X Management Company LLC
Advisor
Global X Management Company LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
Optionable
Options Volume
1
Put Options
82
Call Options
1
Short Interest
37,000 shs

Miscellaneous

Beta
1.14
Creation Unit
50,000
Creation Fee
$500.00
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Top 10 GNOM Holdings

GNOM Sector Exposure

GNOM Industry Exposure


This page (NASDAQ:GNOM) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners